Details of the Drug Reposition

General Information of This Drug (ID: DM776EU)

Drug Name	TVI-Brain-1 cancer vaccine DM776EU

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Brain cancer	DISBKFB7	2A00	Phase 2	[1]
Pneumococcal infection	DIS6SXQD	CA00-CA40	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT01290692) Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma. U.S. National Institutes of Health.